MARPAI, INC. RECEIVES ADDITIONAL $200,000 INVESTMENT FROM DAMIEN LAMENDOLA'S HILLCOUR INVESTMENT FUND
Marpai (OTCQX: MRAI) announced a private placement on Oct 6, 2025 raising approximately $200,000 from HillCour Investment Fund, an entity controlled by CEO Damien Lamendola. The purchase comprised 147,058 shares at $1.36 per share. The company said net proceeds will be used for general corporate purposes, including accelerating product deployment, enhancing its technology platform, and deepening market penetration among self-funded employer groups. Marpai reported a total of $1.7 million raised in Q3 2025. The placement relied on exemptions under Section 4(a)(2) and Regulation D and is not an offer to sell publicly.
Marpai (OTCQX: MRAI) ha annunciato una private placement il 6 ottobre 2025 raccogliendo circa $200.000 dall'HillCour Investment Fund, un ente controllato dal CEO Damien Lamendola. L'acquisto comprendeva 147.058 azioni a $1,36 per azione. L'azienda ha detto che i proventi netti saranno utilizzati per scopi generali aziendali, inclusa l'accelerazione della distribuzione del prodotto, il miglioramento della sua piattaforma tecnologica e un'ulteriore penetrazione nel mercato tra i gruppi di datori di lavoro autofinanziati. Marpai ha riportato un totale di $1,7 milioni raccolti nel terzo trimestre 2025. L'offerta si è basata su esenzioni ai sensi della Sezione 4(a)(2) e del Regolamento D e non costituisce un'offerta di vendita al pubblico.
Marpai (OTCQX: MRAI) anunció una colocación privada el 6 de octubre de 2025 que levantó aproximadamente $200,000 de HillCour Investment Fund, una entidad controlada por el CEO Damien Lamendola. La compra consistió en 147,058 acciones a $1.36 por acción. La empresa dijo que los ingresos netos se usarán para fines corporativos generales, incluyendo acelerar la implementación del producto, mejorar su plataforma tecnológica y profundizar la penetración en el mercado entre grupos de empleadores autofinanciados. Marpai reportó un total de $1.7 millones recaudados en el 3T 2025. La colocación se basó en exenciones de la Sección 4(a)(2) y Regulación D y no constituye una oferta de venta al público.
Marpai (OTCQX: MRAI)는 2025년 10월 6일에 비공개 배치를 발표했으며 HillCour Investment Fund로부터 약 $200,000를 조달했습니다. 이 펀드는 CEO 다미앙 람앙돌라가 지배하는 기관입니다. 매입은 147,058주를 $주당 1.36달러에 체결했습니다. 회사는 순수익이 일반 기업 목적에 사용될 예정이며, 제품 배포 가속화, 기술 플랫폼 강화, 자금 자립형 고용주 그룹 간의 시장 침투 심화를 포함합니다. Marpai는 2025년 3분기에 $170만를 모금했다고 발표했습니다. 본 배치는 제4(a)(2)조 및 규정 D의 면책에 의거하며 공공 판매 제안이 아닙니다.
Marpai (OTCQX: MRAI) a annoncé une placement privé le 6 octobre 2025 ayant levé environ $200 000 auprès de HillCour Investment Fund, une entité contrôlée par le PDG Damien Lamendola. L'achat comprenait 147 058 actions à $1,36 par action. La société a déclaré que les produits nets seront utilisés à des fins générales d'entreprise, notamment pour accélérer le déploiement du produit, améliorer sa plateforme technologique et approfondir la pénétration sur le marché parmi les groupes d'employeurs autofinancés. Marpai a signalé un total de 1,7 million de dollars levés au T3 2025. Le placement reposait sur des exemptions en vertu de la Section 4(a)(2) et du Règlement D et n'est pas une offre de vente au public.
Marpai (OTCQX: MRAI) kündigte eine Privatplatzierung am 6. Oktober 2025 an, bei der rund $200.000 von HillCour Investment Fund, einer vom CEO Damien Lamendola kontrollierten Einheit, aufgenommen wurden. Der Kauf umfasste 147.058 Aktien zu $1,36 pro Aktie. Das Unternehmen gab an, dass die Nettoliquidität für allgemeine Unternehmenszwecke verwendet wird, einschließlich der Beschleunigung der Produktbereitstellung, der Verbesserung seiner Technologieplattform und der weiteren Marktdurchdringung unter selbst finanzierten Arbeitgebergruppen. Marpai berichtete von insgesamt $1,7 Millionen, die im Q3 2025 aufgenommen wurden. Die Platzierung beruhte auf Ausnahmen gemäß Abschnitt 4(a)(2) und Regulation D und ist kein öffentliches Verkaufsangebot.
مارباي (OTCQX: MRAI) أعلن عن توزيع خاص في 6 أكتوبر 2025 جمع حوالي $200,000 من HillCour Investment Fund، كيان يتحكم فيه الرئيس التنفيذي داميان لامندولا. شملت الصفقة 147,058 سهماً بسعر $1.36 للسهم. قالت الشركة إن العائدات الصافية ستستخدم لأغراض عامة للشركة، بما في ذلك تسريع نشر المنتج، وتحسين منصتها التكنولوجية، وتعميق الاختراق السوقي بين مجموعات أصحاب العمل الممولين ذاتياً. قالت مارباي إنها جمعت إجمالاً 1.7 مليون دولار في الربع الثالث من 2025. اعتمدت الصفقة على استثناءات بموجب القسم 4(a)(2) وتنظيم D وليست عرضاً للبيع للجمهور.
Marpai (OTCQX: MRAI) 宣布了一项私人配售，日期为2025年10月6日，从HillCour Investment Fund募集约$200,000，该基金由首席执行官Damien Lamendola控制。此次购买包括147,058股，价格为$1.36/股。公司表示净收益将用于一般企业用途，包括加速产品部署、提升其技术平台以及在自筹资金的雇主群体中进一步渗透市场。Marpai宣布在2025年第三季度共募集$170万美元。此次配售依据第4(a)(2)条款及 Regulation D 的豁免，不构成对公众的销售要约。
- Private placement raised $200,000 via 147,058 shares
- Q3 2025 total capital raised reached $1.7 million
- Proceeds earmarked for technology and product acceleration
- 147,058 shares issued in private placement, which is potentially dilutive
- Investor is an entity controlled by the CEO, creating a related-party transaction
A Total of
"I continue to invest in Marpai because I believe in what we're building—smarter healthcare, better outcomes, and a scalable platform that's disrupting a massive market," said Damien Lamendola, CEO and Director of Marpai, Inc. "My personal commitment—financial and operational—reflects my deep confidence in our team, our technology, and our ability to execute on a growth strategy that I believe will lead to sustainable profitability. I am all in."
The offering is being made in reliance on an exemption from the registration requirement under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), and/or Regulation D promulgated thereunder, and applicable state securities laws. Accordingly, the securities offered in the private placement may not be offered or sold in
This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
About Marpai, Inc.
Marpai, Inc. (OTCQX: MRAI) is a technology platform company which operates subsidiaries that provide TPA and value-oriented health plan services to employers that directly pay for employee health benefits. Primarily competing in the
About HillCour Investment Fund
HillCour Investment Fund is a private investment vehicle managed by Damien Lamendola, focused on high-growth, technology-driven companies positioned for disruptive market impact.
Forward-Looking Statement Disclaimer
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "guidance," "may," "can," "could", "will", "potential", "should," "goal" and variations of these words or similar expressions. For example, the Company is using forward looking statements when it discusses the expected use of proceeds and that Mr. Lamendola's personal financial and operational commitment reflects his deep confidence in the Company's team, technology and its ability to execute on a growth strategy that it believes will lead to sustainable profitability. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect Marpai's current expectations and speak only as of the date of this release. Actual results may differ materially from Marpai's current expectations depending upon a number of factors. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business. Except as required by law, Marpai does not undertake any responsibility to revise or update any forward-looking statements whether as a result of new information, future events or otherwise.
More detailed information about Marpai and the risk factors that may affect the realization of forward-looking statements is set forth in Marpai's filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov.
View original content to download multimedia:https://www.prnewswire.com/news-releases/marpai-inc-receives-additional-200-000-investment-from-damien-lamendolas-hillcour-investment-fund-302576145.html
SOURCE Marpai
FAQ
How much did Marpai (MRAI) raise in the Oct 6, 2025 private placement?
How many shares did HillCour buy in Marpai (MRAI) and at what price?
What will Marpai (MRAI) use the $200,000 private placement proceeds for?
Who controls HillCour Investment Fund that invested in Marpai (MRAI)?
How much capital did Marpai (MRAI) raise in Q3 2025 in total?
